DETERA Therapeutics, a peptide to prevent crescentic glomerulonephritis (CGN)
… treatments are still not effective enough. In October 2024, three co-founders created the start-up DETERA … Bpifrance also provided funding the following month. In June 2025, the start-up was selected by Bpifrance to join the deep tech community. … funding the following month. In June 2025, the start-up was selected by Bpifrance to join the deep tech community. …
Published on: